用于心房颤动的射频导管消融术。

Radiofrequency catheter ablation for atrial fibrillation.

作者信息

Dorn Lauren, Kranzburg Adeline, Saumell Amy, Gregory Tanya, Reich Suzanne

机构信息

Lauren Dorn practices in orthopedic spine surgery at LewisGale Physicians-The Spine Center in Salem, Va. Adeline Kranzburg practices in the medical, surgical, and neurologic ICUs at Wake Forest Baptist Medical Center in Winston-Salem, N.C. Amy Saumell practices dermatology at Judith Crowell, MD, and Associates in Miami, Fla. Tanya Gregory and Suzanne Reich are assistant professors at Wake Forest School of Medicine. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2015 May;28(5):40-5. doi: 10.1097/01.JAA.0000464275.36493.2d.

DOI:10.1097/01.JAA.0000464275.36493.2d

PMID:25909541

Abstract

Antiarrhythmic drugs are the first-line treatment for atrial fibrillation (AF); as a result, catheter ablation usually is not considered until a patient is experiencing symptomatic AF refractory to at least one antiarrhythmic medication or is intolerant to medical therapy. For these patients, catheter ablation is shown to be more effective than medical therapy for controlling AF. This article reviews catheter ablation and its indications.

摘要

抗心律失常药物是心房颤动（AF）的一线治疗方法；因此，通常在患者出现对至少一种抗心律失常药物难治的症状性AF或对药物治疗不耐受之前，不考虑进行导管消融。对于这些患者，导管消融在控制AF方面比药物治疗更有效。本文综述了导管消融及其适应证。